SCHEMBL20828337

SCHEMBL20828337

O=C(Cc1cscn1)Nc1nncs1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 6/20 0.55
SMN1; SMN2 Q16637 3/20 0.55
ESR2 Q92731 1/20 0.55
KDM4E B2RXH2 1/20 0.48
CYP1A2 P05177 1/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2D6 P10635 1/20 0.48
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48
LMNA P02545 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
MAPT P10636 1/20 0.45
TSHR P16473 1/20 0.45
KMT2A Q03164 2/20 0.44
HTT P42858 1/20 0.44
ALDH1A1 P00352 1/20 0.43
HPGD P15428 1/20 0.43
HSD17B10 Q99714 1/20 0.43
GAA P10253 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19914376 0.77 GLS (0.60) POLBSMN1; SMN2ESR2KDM4ECYP1A2
SCHEMBL20828328 0.77 POLB (0.56) POLBSMN1; SMN2ESR2KDM4ECYP1A2
SCHEMBL21501841 0.76 POLB (0.54) POLBSMN1; SMN2ESR2KDM4ECYP1A2
SCHEMBL20828361 0.74 POLB (0.52) POLBSMN1; SMN2ESR2KDM4ECYP1A2
SCHEMBL2872397 0.74 POLB (0.58) POLBSMN1; SMN2ESR2KDM4ECYP1A2
SCHEMBL2872394 0.74 POLB (0.58) POLBSMN1; SMN2ESR2KDM4ECYP1A2
SCHEMBL1758875 0.74 PKM (0.46) SMN1; SMN2KDM4ELMNANPSR1MAPT
SCHEMBL21325740 0.73 POLB (0.74) POLBSMN1; SMN2ESR2KDM4ECYP1A2
SCHEMBL1970389 0.73 POLB (0.56) POLBSMN1; SMN2ESR2KDM4ECYP1A2
SCHEMBL12649504 0.73 POLB (0.60) POLBSMN1; SMN2ESR2KDM4ECYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3456719-A1 COMPOUNDS AND THEIR METHODS OF USE Agios Pharmaceuticals, Inc. (US) 2019-03-20 EP disclosed